TGTX
#1040
TG Therapeutics, Inc. - Common Stock
53.9 3 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.21%
Monthly Change
+0.88%
6 month change
+83.50%
Year Change
+83.62%
Previous Close
55.7 2
Open
53.9 3
Low
53.9 3
High
53.9 3
Volume
115
Financials
- Market Capitalization 8.26 B
- Employee 399
- Founded 1993
- CEO Michael S Weiss
- Website www.tgtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000FVZQY1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
10.76
Price to sales ratio
7.81
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1014 |  IMVT Immunovant, Inc. - Common Stock | 41.20 USD | -5.98% | -6.36% | +4.81% | +114.47% | 8.51 B USD | ||
| 1023 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.97 USD | +0.01% | +0.13% | +0.54% | +151.86% | 8.40 B USD | ||
| 1057 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 90.36 USD | -3.48% | -15.15% | -10.16% | +277.92% | 7.97 B USD | ||
| 1090 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.17 USD | -4.76% | -4.56% | +1.35% | -2.85% | 7.38 B USD |
Frequently asked questions about TG Therapeutics, Inc.
What is the TG Therapeutics, Inc. stock price today?
The current price of TG Therapeutics, Inc. (TGTX) is 53.93. Over the past 24 hours, the stock has changed by -3.21%. Follow the TGTX chart for real-time price dynamics.
What is the stock ticker of TG Therapeutics, Inc.?
TG Therapeutics, Inc. trades under the ticker TGTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is TG Therapeutics, Inc. stock going up?
TGTX has changed by +1.39% over the last week, +0.88% over the last month, and +83.62% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of TG Therapeutics, Inc.?
TG Therapeutics, Inc. currently has a market capitalization of 8.26 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were TG Therapeutics, Inc. earnings last quarter?
Last quarter, TG Therapeutics, Inc. reported earnings of 0.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was TG Therapeutics, Inc. revenue for the last quarter?
TG Therapeutics, Inc. reported quarterly revenue of 240.34 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was TG Therapeutics, Inc. net income for the last quarter?
TG Therapeutics, Inc. reported net income of 7.78 M for the last quarter. The previous quarter showed 19.78 M, which means net income changed by -60.66%.
How many employees does TG Therapeutics, Inc. have?
As of the latest available data, TG Therapeutics, Inc. has 399 employees. Workforce size can provide additional context about the company's scale and operations.
What is TG Therapeutics, Inc. EBITDA?
TG Therapeutics, Inc. EBITDA is 21.73 M, and its EBITDA margin is 9.04%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy TG Therapeutics, Inc. stock?
You can buy TG Therapeutics, Inc. (TGTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in TG Therapeutics, Inc. stock?
Investing in TG Therapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TGTX chart and related analysis on metatrader.com as part of your research.